• No. 250 Wu-Xing Street

    11031 Taipei

Organization profile

Organisation profile

Founded in 1989, TMU School of Public Health is one of the leading authorities in the field of public health research in Taiwan.

It is a pioneer in applying its knowledge and expertise in the field, and educating scientists and practitioners to work toward the improvement of health and quality of lives through lifelong learning and teamwork. Master and doctoral programs started to recruit students since 1996 and 2001, respectively.

Aiming to train qualified public health specialists in disease prevention and health promotion, the School offers concentrations in Environmental Health, Epidemiology, and Community Health. During the years of 2002-2008, the School recruited master students with concentration in Health Communication. Starting August 2010, the School started to reach globally and has been enriched by international students. Our mission is to provide highest public health education internationally.

Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit

Taiwan Medicine & Life Sciences
Arsenic Medicine & Life Sciences
Population Medicine & Life Sciences
Confidence Intervals Medicine & Life Sciences
Stroke Medicine & Life Sciences
Cohort Studies Medicine & Life Sciences
Polymorphism Chemical Compounds
Odds Ratio Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2010 2019

Research Output 1985 2019

Fathers
Longitudinal Studies
Anxiety
Mothers
Quality of Life

Adiponectin gene polymorphisms and obesity increase the susceptibility to arsenic-related renal cell carcinoma

Hsueh, Y. M., Chen, W. J., Lin, Y. C., Huang, C. Y., Shiue, H. S., Yang, S. M., Ao, P. L., Pu, Y. S. & Su, C. T., Jul 1 2018, In : Toxicology and Applied Pharmacology. 350, p. 11-20 10 p.

Research output: Contribution to journalArticle

Adiponectin
Arsenic
Polymorphism
Renal Cell Carcinoma
Obesity

Aspirin associated with risk reduction of secondary primary cancer for patients with head and neck cancer: A population-based analysis

Lin, Y. S., Yeh, C. C., Huang, S. F., Chou, Y. S., Kuo, L. T., Sung, F. C., Muo, C. H., Su, C. T. & Su, F. H., Aug 1 2018, In : PloS one. 13, 8, e0199014.

Research output: Contribution to journalArticle

aspirin
risk reduction
Risk Reduction Behavior
Head and Neck Neoplasms
Aspirin